World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
98
Citations
44184
World Ranking
796
National Ranking
61

Overview

Brit Mollenhauer is affiliated with the University of Göttingen in Germany. Their primary field of study is Medicine, with a focus on Neurology, Physiology, Molecular Biology, Cellular and Molecular Neuroscience, and Cognitive Neuroscience.

Their research primarily covers topics related to Parkinson's Disease mechanisms and treatments, neurological disorders and treatments, Alzheimer's disease research and treatments, neurological diseases and metabolism, nuclear receptors and signaling, lysosomal storage disorders research, and RNA regulation and disease.

Frequent co-authors of Brit Mollenhauer include Claudia Trenkwalder, Friederike Sixel-Döring, Andrew Siderowf, Lana M. Chahine, and Kenneth Marek.

The scientist has published extensively in several venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • npj Parkinson s Disease
  • Movement Disorders
  • Neurology
  • Movement Disorders Clinical Practice

Notable recent papers by Brit Mollenhauer include:

  • Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study, 2023, The Lancet Neurology
  • A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research, 2024, The Lancet Neurology
  • Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium, 2020, Newcastle University ePrints (Newcastle University)
  • Trial of Prasinezumab in Early-Stage Parkinson's Disease, 2022, New England Journal of Medicine
  • Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide, 2020, Movement Disorders Clinical Practice

Best Publications

  • Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium

    Ian G. McKeith;Bradley F. Boeve;Dennis W. DIckson;Glenda Halliday

  • Diagnostic Criteria for Mild Cognitive Impairment in Parkinson’s Disease: Movement Disorder Society Task Force Guidelines

    Irene Litvan;Jennifer G. Goldman;Alexander I. Tröster;Ben A. Schmand

  • Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

    Günter U Höglinger;Gesine Respondek;Maria Stamelou;Carolin Kurz

  • Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.

    Ludovico Cantuti-Castelvetri;Ludovico Cantuti-Castelvetri;Ravi Ojha;Liliana D. Pedro;Liliana D. Pedro;Minou Djannatian;Minou Djannatian

  • The Parkinson Progression Marker Initiative (PPMI)

    Kenneth Marek;Danna Jennings;Shirley Lasch;Andrew Siderowf

  • A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease

    Alexander Zimprich;Anna Benet-Pagès;Walter Struhal;Elisabeth Graf

  • Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study

    Ronald B Postuma;Alex Iranzo;Michele Hu;Birgit Högl

  • MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI

    Irene Litvan;Dag Aarsland;Charles H. Adler;Jennifer G. Goldman

  • α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

    Brit Mollenhauer;Brit Mollenhauer;Joseph J Locascio;Walter Schulz-Schaeffer;Friederike Sixel-Döring

  • Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study

    Unknown

  • Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy

    Günter U. Höglinger;Nadine M. Melhem;Dennis W. Dickson;Patrick M A Sleiman

  • The Parkinson's progression markers initiative (PPMI): establishing a PD biomarker cohort

    Kenneth Marek;Sohini Chowdhury;Andrew Siderowf;Shirley Lasch

  • CSF and blood biomarkers for Parkinson's disease.

    Lucilla Parnetti;Lorenzo Gaetani;Paolo Eusebi;Silvia Paciotti

  • A Practical Guide to Immunoassay Method Validation

    Ulf Andreasson;Armand Perret-Liaudet;Linda J C van Waalwijk van Doorn;Kaj Blennow

  • Characterizing mild cognitive impairment in incident Parkinson disease The ICICLE-PD Study

    Alison J Yarnall;David P Breen;Gordon W Duncan;Tien K Khoo

  • Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid

    Mohammad Shahnawaz;Takahiko Tokuda;Masaaki Waragai;Nicolas Mendez

  • Trial of Prasinezumab in Early-Stage Parkinson's Disease.

    Unknown

  • Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

    Brit Mollenhauer;Valerie Cullen;Ilana Kahn;Bryan Krastins

  • Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies

    Anne Stuendl;Marcel Kunadt;Niels Kruse;Claudia Bartels

  • Trial of Cinpanemab in Early Parkinson's Disease.

    Unknown

  • Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease

    Ju-Hee Kang;Ju-Hee Kang;David J. Irwin;Alice S. Chen-Plotkin;Andrew Siderowf

  • Associated factors for REM sleep behavior disorder in Parkinson disease.

    Friederike Sixel-Döring;Ellen Trautmann;Brit Mollenhauer;Claudia Trenkwalder

  • Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

    Marta del Campo;Brit Mollenhauer;Antonio Bertolotto;Sebastiaan Engelborghs

  • Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease.

    M. Otto;J. Wiltfang;L. Cepek;M. Neumann

  • MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity.

    Nadiya M. Teplyuk;Brit Mollenhauer;Galina Gabriely;Alf Giese

Frequent Co-Authors

Claudia Trenkwalder
Claudia Trenkwalder University of Göttingen
Daniela Berg
Daniela Berg University Hospital Schleswig-Holstein
Henrik Zetterberg
Henrik Zetterberg University of Gothenburg
Caroline M. Tanner
Caroline M. Tanner University of California, San Francisco
Michele T.M. Hu
Michele T.M. Hu University of Oxford
Daniel Weintraub
Daniel Weintraub University of Pennsylvania
Ziv Gan-Or
Ziv Gan-Or McGill University
Guy A. Rouleau
Guy A. Rouleau Montreal Neurological Institute and Hospital
Kaj Blennow
Kaj Blennow University of Gothenburg
Dag Aarsland
Dag Aarsland King's College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in neuroscience doesn’t have to follow a traditional path. Many students interested in the brain and behavior often consider related online programs in psychology, social work, and family therapy. These fields can offer flexible pathways for those eager to enter the workforce quickly or specialize in mental health and counseling roles.

For those seeking affordability and convenience, enrolling in an online psychology degree is a popular option. Individuals hoping to transition into social work without previous experience may find 1 year msw programs online no bsw to be especially accessible and time-effective.

Advanced learners interested in clinical practice might consider earning a psyd psychology online, which focuses on hands-on therapy skills and prepares graduates for licensure. Likewise, those passionate about family and relationships might pursue one of the best online mft programs for a direct path to a career as a marriage and family therapist.

Each of these online degrees offers unique opportunities and career outcomes that complement a background—or interest—in neuroscience.

Best Scientists Citing Brit Mollenhauer

Trending Scientists